Graham Capital Management, L.P.
Position in CRL — Charles River Laboratories International, Inc.
CIK 1315421
ROWAYTON, CT
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$329,752
New position
Shares Held
1,454
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#356
of 569 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Graham Capital Management, L.P. holds $10,662,805 across 8 Diagnostics & Research names. CRL ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
25,748 | $6,989,294 | |
| 2 | DHR |
Danaher Corp /De/
|
10,612 | $2,021,373 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
879 | $462,740 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
839 | $444,326 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,454 | $329,752 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,121 | $216,599 | |
| 7 | MYGN |
Myriad Genetics Inc
|
28,804 | $164,470 | |
| 8 | OPK |
Opko Health, Inc.
|
22,834 | $34,251 |
All Filings in CRL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329,752 | 1,454 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||